Evidence map›Paper›PMID 34003330›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2021

LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1.

Mahesh Pandit, Maheshwor Timilshina, Jae-Hoon Chang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Complex Interplay Between Metabolism and CD4Cardiovascular drugs and therapy · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Artesunate targets cellular metabolism to regulate the Th17/Treg cell balance.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  15. Review
  16. Review
  17. Article
  18. AMPK suppresses Th2 cell responses by repressing mTORC2.Experimental & molecular medicine · 2022
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mahesh PanditCollege of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Maheshwor TimilshinaCollege of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Jae-Hoon ChangCollege of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea. jchang@yu.ac.kr.ORCID 0000-0002-1001-6570
Yeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immuno-environmental change triggers CD4

Indexed as

Cell DifferentiationAMP-Activated Protein KinasesAnimalsBiomarkersGene Expression RegulationGlycolysisHypoxia-Inducible Factor 1, alpha SubunitImmunohistochemistryImmunophenotypingMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MiceMice, KnockoutPhosphorylationProtein BindingPTEN PhosphohydrolaseAMP-Activated Protein KinasesBiomarkersHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2PTEN PhosphohydrolasePten protein, mouseStk11 protein, mouseAutoimmunityGlycolysisLKB1-PTENT cell

Identifiers

PMID34003330
OpenAlexW3162612359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.